Pursuant to the Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with Regulation 82(4) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, please find enclosed the Report(s) of the Monitoring Agency for the quarter ended June 30, 2025, issued by CRISIL Ratings Limited, Monitoring Agency appointed to monitor the utilization of the proceeds of the Rights Issue and Qualified Institutional Placement of the Company.
SAMMAANCAP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sammaan Capital has filed CRISIL Ratings' monitoring agency reports on the use of proceeds from its January 2025 Qualified Institutional Placement (QIP) and February 2024 Rights Issue for the quarter ended June 30, 2025. The QIP raised Rs 13,000 million (net Rs 12,648.9 million), of which Rs 9,593.9 million was for augmenting the capital base (fully utilised) and Rs 3,055 million for general corporate purposes, with only Rs 15.94 million remaining unutilised. The Rights Issue raised Rs 36,933.98 million gross (net Rs 36,134.68 million), with Rs 27,108.81 million deployed for capital augmentation and Rs 8,722.22 million for general corporate purposes, leaving Rs 303.64 million unutilised (partly because Rs 301.53 million is yet to be received via subsequent calls). CRISIL confirmed no deviation from the stated objects, no delays, and no major issues.
This is a routine regulatory compliance filing rather than a new corporate action. It shows the company has used the QIP and Rights Issue proceeds largely as planned, with only small amounts left unutilised, which is a neutral-to-mildly-positive governance signal. Investors awaiting the next growth push from the deployed capital will look to subsequent quarterly results to see the impact on the loan book.